Last updated on May 2019

A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer


Brief description of study

The purpose of this study is to evaluate the prevalence of 4 or more DNA-repair defects in a population of men with metastatic Prostate Cancer (PC) and to use the variants reported to assess biomarker eligibility for niraparib interventional studies.

Clinical Study Identifier: NCT03871816

Find a site near you

Start Over

University of Virginia

Charlottesville, VA United States
5.55miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.